GlassScriptPhysician profile
Tung Nguyen
NPI 1700317120
$1,644.86
in general payments reported to CMS, 2019-2025
16 companies · $177 in 2025
The $177 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $274 · 2023: $808 · 2024: $385 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,370.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $212.37 | 2022-2023 | Azure Xt Dr Mri Surescan, Evera Mri Xt Dr Surescan, Cobalt Dr Mri Surescan |
| Astrazeneca Pharmaceuticals LP | $200.15 | 2022-2023 | Farxiga |
| Abbott Laboratories | $178.06 | 2022-2025 | Cardiomems |
| Pfizer INC. | $151.85 | 2024-2025 | |
| Boston Scientific Corporation | $149.68 | 2023 | |
| Janssen Pharmaceuticals, INC | $125.00 | 2024 | Xarelto |
| Amgen INC. | $117.41 | 2023 | Repatha |
| Abiomed | $113.48 | 2023 | Impella |
| Sanofi-Aventis U.S. LLC | $104.50 | 2023 | |
| Janssen Scientific Affairs, LLC | $80.15 | 2024 | Xarelto |
| Novo Nordisk INC | $78.72 | 2025 | Wegovy |
| Biotronik INC. | $51.93 | 2022-2024 | Orsiro Mission |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.30 | 2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $22.13 | 2024 | |
| Getinge USA Sales, LLC | $20.23 | 2023 | Cardiosave Hybrid, Type B Plug |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $16.90 | 2024 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tung Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.